<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01097863</url>
  </required_header>
  <id_info>
    <org_study_id>P-346-C-010</org_study_id>
    <nct_id>NCT01097863</nct_id>
  </id_info>
  <brief_title>Clinical Validation of the New Print on Focus DAILIES Toric</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>CIBA VISION</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Alcon Research</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to validate the improvements to the inversion indicator.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study was conducted in three countries under three separate protocols: P-346-C-009 sub
      02 (UK), P-346-C-009 sub 03 (Germany), and P-346-C-010 (USA). The data reported represents
      pooled data from the three protocols.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2010</start_date>
  <completion_date type="Actual">May 2010</completion_date>
  <primary_completion_date type="Actual">May 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visibility of the Inversion Indicator on Lens When Lens Was on Participant's Finger, for Example, During Lens Insertion.</measure>
    <time_frame>1 week</time_frame>
    <description>As assessed by the participant retrospectively after one week of wear and recorded on a questionnaire as a yes or no response to the question, &quot;Did you notice an OK mark on the study lens while it was on your finger, for example, during lens insertion?&quot; The positive &quot;yes&quot; responses are reported.</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">280</enrollment>
  <condition>Myopia</condition>
  <arm_group>
    <arm_group_label>nelfilcon A, modified inversion indicator</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Nelfilcon A investigational contact lenses worn in both eyes on a daily wear, daily disposable basis for one week</description>
  </arm_group>
  <arm_group>
    <arm_group_label>nelfilcon A, no inversion indicator</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Nelfilcon A investigational contact lenses worn in both eyes on a daily wear, daily disposable basis for one week</description>
  </arm_group>
  <arm_group>
    <arm_group_label>nelfilcon A, inversion indicator</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Nelfilcon A commercially marketed contact lenses worn in both eyes on a daily wear, daily disposable basis for one week.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>nelfilcon A contact lens, modified inversion indicator</intervention_name>
    <description>Investigational, nelfilcon A, toric, soft contact lens for daily disposable wear, with modified inversion indicator</description>
    <arm_group_label>nelfilcon A, modified inversion indicator</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>nelfilcon A contact lens, no inversion indicator</intervention_name>
    <description>Investigational, nelfilcon A, toric, soft contact lens for daily disposable wear, with no inversion indicator</description>
    <arm_group_label>nelfilcon A, no inversion indicator</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>nelfilcon A contact lens, inversion indicator</intervention_name>
    <description>Commercially marketed, nelfilcon A, toric, soft contact lens for daily disposable wear, with inversion indicator</description>
    <arm_group_label>nelfilcon A, inversion indicator</arm_group_label>
    <other_name>Focus DAILIES Toric</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Be of legal age and sign written Informed Consent Document. If under legal age, parent
             or guardian must sign Informed Consent Document and subjects ages 12 through 17 must
             sign Informed Assent.

          -  Willing and able to wear study lenses in both eyes in the available parameters.

          -  Light-eyed subjects.

          -  Able to achieve 20/40 or better distance visual acuity (VA) in each eye at time of
             dispensing.

          -  Optimal or acceptable fit in each eye at time of dispensing.

          -  Willing to wear the study lenses at least 8 hours a day, 5 days a week.

          -  Other protocol-defined inclusion criteria may apply.

        Exclusion Criteria:

          -  Eye injury or surgery within twelve weeks prior to enrollment for this trial.

          -  Pre-existing ocular irritation that would preclude contact lens fitting.

          -  Currently enrolled in an ophthalmic clinical trial.

          -  Evidence of systemic or ocular abnormality, infection or disease which is likely to
             affect successful wear of contact lenses or use of their accessory solutions as
             determined by the investigator.

          -  Any use of medications for which contact lens wear could be contraindicated as
             determined by the investigator.

          -  RGP contact lens wearer.

          -  Other protocol-defined exclusion criteria may apply.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <removed_countries>
    <country>United States</country>
  </removed_countries>
  <verification_date>January 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 31, 2010</study_first_submitted>
  <study_first_submitted_qc>March 31, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 2, 2010</study_first_posted>
  <results_first_submitted>May 27, 2011</results_first_submitted>
  <results_first_submitted_qc>May 27, 2011</results_first_submitted_qc>
  <results_first_posted type="Estimate">June 27, 2011</results_first_posted>
  <last_update_submitted>June 26, 2012</last_update_submitted>
  <last_update_submitted_qc>June 26, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 10, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>

  <clinical_results>

    <participant_flow>
      <pre_assignment_details>This reporting group includes all enrolled and dispensed participants. Note: One subject was enrolled but not dispensed due to failing inclusion/exclusion criteria.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Nelfilcon A, Modified Inversion Indicator</title>
          <description>nelfilcon A investigational contact lenses worn in both eyes on a daily wear, daily disposable basis for one week</description>
        </group>
        <group group_id="P2">
          <title>Nelfilcon A, No Inversion Indicator</title>
          <description>nelfilcon A investigational contact lenses worn in both eyes on a daily wear, daily disposable basis for one week</description>
        </group>
        <group group_id="P3">
          <title>Nelfilcon A, Inversion Indicator</title>
          <description>nelfilcon A commercially marketed contact lenses worn in both eyes on a daily wear, daily disposable basis for one week.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="90"/>
                <participants group_id="P2" count="98"/>
                <participants group_id="P3" count="91"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="89"/>
                <participants group_id="P2" count="98"/>
                <participants group_id="P3" count="89"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Discomfort</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Did not return for final visit</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Nelfilcon A, Modified Inversion Indicator</title>
          <description>nelfilcon A investigational contact lenses worn in both eyes on a daily wear, daily disposable basis for one week</description>
        </group>
        <group group_id="B2">
          <title>Nelfilcon A, No Inversion Indicator</title>
          <description>nelfilcon A investigational contact lenses worn in both eyes on a daily wear, daily disposable basis for one week</description>
        </group>
        <group group_id="B3">
          <title>Nelfilcon A, Inversion Indicator</title>
          <description>nelfilcon A commercially marketed contact lenses worn in both eyes on a daily wear, daily disposable basis for one week.</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="90"/>
            <count group_id="B2" value="98"/>
            <count group_id="B3" value="91"/>
            <count group_id="B4" value="279"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="36.2" spread="10.6"/>
                    <measurement group_id="B2" value="33.3" spread="11.7"/>
                    <measurement group_id="B3" value="34.1" spread="10.8"/>
                    <measurement group_id="B4" value="34.5" spread="11.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="52"/>
                    <measurement group_id="B2" value="69"/>
                    <measurement group_id="B3" value="69"/>
                    <measurement group_id="B4" value="190"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="38"/>
                    <measurement group_id="B2" value="29"/>
                    <measurement group_id="B3" value="22"/>
                    <measurement group_id="B4" value="89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Visibility of the Inversion Indicator on Lens When Lens Was on Participant's Finger, for Example, During Lens Insertion.</title>
        <description>As assessed by the participant retrospectively after one week of wear and recorded on a questionnaire as a yes or no response to the question, &quot;Did you notice an OK mark on the study lens while it was on your finger, for example, during lens insertion?&quot; The positive &quot;yes&quot; responses are reported.</description>
        <time_frame>1 week</time_frame>
        <population>Analysis conducted per protocol, with exclusions due to protocol deviations as determined by masked review (9), and unavailable data due to discontinuations (3).</population>
        <group_list>
          <group group_id="O1">
            <title>Nelfilcon A, Modified Inversion Indicator</title>
            <description>nelfilcon A investigational contact lenses worn in both eyes on a daily wear, daily disposable basis for one week</description>
          </group>
          <group group_id="O2">
            <title>Nelfilcon A, No Inversion Indicator</title>
            <description>nelfilcon A investigational contact lenses worn in both eyes on a daily wear, daily disposable basis for one week</description>
          </group>
          <group group_id="O3">
            <title>Nelfilcon A, Inversion Indicator</title>
            <description>nelfilcon A commercially marketed contact lenses worn in both eyes on a daily wear, daily disposable basis for one week.</description>
          </group>
        </group_list>
        <measure>
          <title>Visibility of the Inversion Indicator on Lens When Lens Was on Participant's Finger, for Example, During Lens Insertion.</title>
          <description>As assessed by the participant retrospectively after one week of wear and recorded on a questionnaire as a yes or no response to the question, &quot;Did you notice an OK mark on the study lens while it was on your finger, for example, during lens insertion?&quot; The positive &quot;yes&quot; responses are reported.</description>
          <population>Analysis conducted per protocol, with exclusions due to protocol deviations as determined by masked review (9), and unavailable data due to discontinuations (3).</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="86"/>
                <count group_id="O2" value="97"/>
                <count group_id="O3" value="84"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="77"/>
                    <measurement group_id="O2" value="15"/>
                    <measurement group_id="O3" value="84"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse event data was collected for the duration of the trial: 78 days</time_frame>
      <desc>This reporting group includes all enrolled and exposed participants: 280</desc>
      <group_list>
        <group group_id="E1">
          <title>Nelfilcon A, Modified Inversion Indicator</title>
          <description>nelfilcon A investigational contact lenses worn in both eyes on a daily wear, daily disposable basis for one week</description>
        </group>
        <group group_id="E2">
          <title>Nelfilcon A, No Inversion Indicator</title>
          <description>nelfilcon A investigational contact lenses worn in both eyes on a daily wear, daily disposable basis for one week</description>
        </group>
        <group group_id="E3">
          <title>Nelfilcon A, Inversion Indicator</title>
          <description>nelfilcon A commercially marketed contact lenses worn in both eyes on a daily wear, daily disposable basis for one week.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="90"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="92"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="6" subjects_at_risk="90"/>
                <counts group_id="E2" subjects_affected="13" subjects_at_risk="98"/>
                <counts group_id="E3" subjects_affected="13" subjects_at_risk="92"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Other contact lens symptoms not requiring treatment</sub_title>
                <description>Participants reported on a questionnaire the nature, frequency and severity of any/all lens-related symptoms experienced with lens wear. Any frequency and/or severity significantly higher with study lenses than with habitual was an adverse event.</description>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="90"/>
                <counts group_id="E2" events="13" subjects_affected="13" subjects_at_risk="98"/>
                <counts group_id="E3" events="13" subjects_affected="13" subjects_at_risk="92"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>For a period of 10 years, the clinical investigator must hold all trial-related information and documents confidential and must agree to obtain sponsor's written consent before discussion, presenting, publicizing, or otherwise disclosing any preclinical and/or clinical data or impressions from this trial.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs</name_or_title>
      <organization>CIBA VISION</organization>
      <phone>1-800-241-7629</phone>
      <email>priya.janakiraman@cibavision.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

